HIV-related pulmonary hypertension. From pathogenesis to clinical aspects

References

• Kim KK, Factor SM. Membrano-proliferative glomeru-lonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome. Hum Pathol 1987; 18: 1293–6.
   Google Scholar
• Metha NJ, Khan IA, Metha RN, Sepkowitz A. HIV-related pulmonary hypertension. Analytic review of 131 cases. Chest 2000; 118: 1133–41.
   Google Scholar
• Rich S, ed. Executive summary from the world sympo-sium on primary pulmonary hypertension. 1998 Evian, France, September 6–10 1998, co-sponsored by World Health Organization, retrieved April 14, 2000 from www.who.int/ncd/cvd/pph.html.
   Google Scholar
• Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest 1991; 100: 1268–71.
   Google Scholar
• Mette SA, Palevsky HI, Pietra GG, Williams TM, Bruder E, Prestipino AJ, Patrick AM, Wirth JA. Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 1992; 145: 1196–200.
   Google Scholar
• Humbert M, Monti G, Fartouk M, Magnan A, Brenot F, Rain B, Capron F, Galanaud P, Duroux P, Simonneau G, Emilie D. Platelet-derived growth factor expression in pri-mary pulmonary hypertension: comparison of HIV seropos-itive and HIV seronegative patients. Eur Respir J 1998; 11: 554–9.
   Google Scholar
• Pellicelli AM, Palmieri F, Cicalini S, Petrosillo N. Patho-genesis of HIV related pulmonary hypertension. Ann N Y Acad Sci 2001; 946: 82–94.
   Google Scholar
• Giaid A, Yanagisawa M, Langleben D. Expression of endothelin-1 in the lungs of patients with pulmonary hyper-tension. N Engl J Med 1993; 328: 1732–9.
   Google Scholar
• Giaid A. Nitric oxide and endothelin-1 in pulmonary hyper-tension. Chest 1998; 114: 208S–212S.
   Google Scholar
• Cacoub P, Dorent R, Nataf P, Carayon A, Riquet M, Noe E, Piette JC, Godeau P, Gandjbakhch I. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997; 33: 196–200.
   Google Scholar
• Humbert M, Monti P, Brenot F, Sitbon 0, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin 6 serum concentrations in severe primary pulmonary hypertension. Am J Crit Care Med 1995; 151: 1628–31.
   Google Scholar
• Pellicelli AM, Palmieri F, D’Ambrosio C, Rianda A, Boumis E, Girardi E, Antonucci G, D’amato C, Borgia MC. Role of human immunodeficiency virus in primary pul-monary hypertension-case reports. Angiology 1998; 49: 1005–11.
   Google Scholar
• Salvi SS. Alfal-adrenergic hypothesis for pulmonary hyper-tension. Chest 1999; 115: 1708–19.
   Google Scholar
• Tomashefski JF, Hirsch CS. The pulmonary vascular lesions of intravenous drug abuse. Hum Pathol 1980; 11: 133–45.
   Google Scholar
• Pellicelli AM, Barbaro G, Palmieri F, Girardi E, D’Ambro-sio C, Rianda A, Barbarini G, Frigiotti D, Borgia MC. Primary pulmonary hypertension in HIV patients: a sys-tematic review. Angiology 2001; 52: 31–41.
   Google Scholar
• Branch CA, Knuepfer MM. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats. J Pharmacol Exp Ther 1992; 263: 742–51.
   Google Scholar
• Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pul-monary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gas-troenterology 1991; 100: 520–8.
   Google Scholar
• Kuddus RH, Nalesnik MA, Subbotin VM, Rao AS, Gandhi CR. Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes - an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J Hepatol 2000; 33: 725–32.
   Google Scholar
• Morse JH, Barst RJ, Itescu S, Flaster ER, Sinha G, Zhang Y, Fotino M. Primary pulmonary hypertension in HIV infection. An outcome determined by particular HLA class II alleles. Am J Respir Crit Care Med 1996; 153: 1299–301.
   Google Scholar
• Itescu S, Dalton J, Zhang HZ, Winchester R. Tissue infil-tration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the pheno-typic appearance of an antigenically driven responce. J Clin Invest 1993; 91: 2216–25.
   Google Scholar
• Itescu S, Brancato LJ, Winchester W A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lym-phocytosis. Lancet 1989; 2: 466–8.
   Google Scholar
• Deng Z, Morse, JH, Slager, SL, Cuervo N, Moore KJ, Vene-tos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA. Familial primary pulmonary hyper-tension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000; 67: 737–44.
   Google Scholar
• Nunes H, Humbert M, Sitbon 0, Morse JH, Deng Z, Knowles JA, Le Gall C, Parent F, Garcia G, Herve P, Barst RJ, Simonneau G. Am J Respir Grit Care Med 2003; 167: 1433–9.
   Google Scholar
• Cone JO, Moreau R, Godinho E. Diagnosis of portopul-monary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003; 37: 401–9.
   Google Scholar
• Opravil M, Pechere M, Speich R, Joller-Jemelka HI, Jenni R, Russi EW, Hirschel B, Luthy R. HIV-associated primary pulmonary hypertension. Am J Respir Grit Care Med 1997; 155: 990–5.
   Google Scholar
• Speich R, Jenni R, Opravil M, Jenni R, Jaccard R. Regres-sion of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy. Swiss Med Wkly 2001; 131: 663–5.
   Google Scholar
• Petiprez P, Brenot F, Azarian R, Parent F, Rain B, Herve P, Simonneau G. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation 1994; 89: 2722–7.
   Google Scholar
• Aguilar R, Farber HW. Epoprostenol (prostacyclin) therapy in HIV associated pulmonary hypertension. Am J Respir Grit Care Med 2000; 162: 1846–50.
   Google Scholar
• Hashida H, Hamada M, Shigematsu Y, Ikeda S, Kuwa-hara T, Kawakami H, Hara Y, Kodama K, Kohara K, Hiwada K. Beneficial hemodynamic effects of oral prosta-cyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension — a case report. Angiology 1998; 49: 161–4.
   Google Scholar
• Galie N, Humbert M, Vachiery JL, Vizza CD, Kneussl M, Manes A, Sitbon 0, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G.Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a ran-domized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002; 39: 1496–502.
   Google Scholar
• Vizza CD, Sciomer S, Morelli S, Lavalle C, Di Marzio P, Padovani D, Badagliacca R, Vestri AR, Naeije R, Fedele F. Long-term treatment of pulmonary arterial hypertension with beraprost, an oral pro stacyclin analogue. Heart 2001; 86: 661–5.
   Google Scholar
• Polos PG, Wolfe D, Harley RA, Strange C, Sahn SA. Pulmonary hypertension and human immunodeficiency virus infection: two reports and a review of the literature. Chest 1992; 101: 474–8.
   Google Scholar
• Rhodes J, Schiller MS, Montoya CH, Fikrig S. Severe pulmonary hypertension without significant pulmonary parenchymal disease in a pediatric patient with acquired immunodeficiency syndrome. ClM Pediatr 1992; 31: 629–31.
   Google Scholar
• Abrams D, Schulze-Neick I, Magee AG. Sildenafil as a selec-tive pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 2000; 84: E4.
   Google Scholar
• Carlsen J, Kjeldsen K, Gerstoft J. Sildenafil as a successful treatment of otherwise fatal HIV related pulmonary hyper-tension. AIDS 2002; 16: 1568–9.
   Google Scholar
• Sanchez LS, de la Monte SM, Filippov G, Jones RC, Zapol WM, Bloch KD. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regu-lated during rat pulmonary development. Pediatr Res 1998; 43: 163–8.
   Google Scholar
• Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896–903.
   Google Scholar